You are here

AusPAR: Tofacitinib (as citrate)

Related information


How to access a pdf or Word document

*Large file warning: Attempting to open large files over the Internet within the browser window may cause problems. It is strongly recommended you download this document to your own computer and open from there.

Australian Public Assessment Report

16 October 2019
AusPAR Details
AusPAR
Active Ingredient
Tofacitinib (as citrate)
Product Name
Xeljanz
Sponsor
Pfizer Australia Pty Ltd
Submission Number
PM-2017-03802-1-3
Submission Type
Extension of indications
Decision
Approved
AusPAR Date
25 September 2019
Publication Date

16 October 2019